Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP)

Author:

Schmulenson Eduard1ORCID,Bovet Cédric2,Theurillat Regula2,Decosterd Laurent Arthur3,Largiadèr Carlo R.2,Prost Jean‐Christophe2,Csajka Chantal4,Bärtschi Daniela5,Guckenberger Matthias6,von Moos Roger7,Bastian Sara7,Joerger Markus8,Jaehde Ulrich1ORCID

Affiliation:

1. Institute of Pharmacy, Department of Clinical Pharmacy University of Bonn Bonn Germany

2. Department of Clinical Chemistry, Inselspital Bern University Hospital and University of Bern Bern Switzerland

3. Laboratory of Clinical Pharmacology Lausanne University Hospital and University of Lausanne Lausanne Switzerland

4. Clinical Pharmaceutical Sciences Lausanne University Lausanne Switzerland

5. SAKK Coordinating Center Bern Switzerland

6. Department of Radiation Oncology University Hospital Zurich, University of Zurich Zurich Switzerland

7. Cantonal Hospital Graubünden Chur Switzerland

8. Department of Medical Oncology and Hematology Cantonal Hospital St. Gallen St. Gallen Switzerland

Funder

Bayer Portugal

Krebsliga Schweiz

Swiss Cancer Research Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3